Novartis Bioventures Ltd, 10% Owner at Akebia Therapeutics, Inc. (AKBA), bought 3,405,764 shares at $17.00 ($3.1M) on 2014-03-25, disclosed to the SEC on 2014-03-27.
Open-market purchase of $3.1M AKBA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,223,174 | $0 | 0.0% |
| 2 | $17.00 | 182,590 | $3.1M | 100.0% |
| Total | $0.91 avg | 3,405,764 | $3.1M | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |